Related by context. All words. (Click for frequent words.) 82 Drug Shows Promise 82 Files IND 80 Licenses Novel 80 Develop Next Generation 80 Receives Orphan Drug Designation 80 FDA Clears 80 Receives Milestone Payment 79 Completes Patient Enrollment 79 FDA Okays 79 Commercialize Novel 79 Submits NDA 79 Announce License Agreement 79 Announce Collaboration Agreement 79 Commercialize 79 Initiates Clinical Trial 78 Shows Promise Against 78 Shows Promise 78 Present Preclinical Data 78 Arthritis Drug 78 Sign Licensing Agreement 78 Announces FDA Clearance 78 Drug Candidate 78 Immune Cells 78 Develop Innovative 77 Initiates Enrollment 77 Presents Preclinical Data 77 Holds Promise 77 Nicotine Vaccine 77 Initiates Phase III 77 Initiates Clinical 77 Epilepsy Drug 77 Milestone Payment 77 Initiates Phase II 77 Shows Promising 77 Novel Therapeutic 76 Files Patent Application 76 Accelerate Commercialization 76 Receives FDA Clearance 76 Receives Patent 76 Molecular Diagnostic Test 76 Improves Survival 76 Completes Enrollment 76 Drug Fails 76 Reduces Risk 76 Initiates Dosing 76 Effectively Treats 76 Receives Approvable Letter 76 Announce Collaboration 76 Presents Positive 76 Sign License Agreement 76 RNAi Therapeutics 76 Osteoporosis Drug 76 Achieves Milestone 76 Prolongs Survival 76 Small Molecule 76 Scientists Develop 76 Meets Primary Endpoint 76 Genes Linked 76 Receives Orphan Drug 76 Novel Compounds 76 Preclinical Data 76 Expand Collaboration 76 Collaborators Publish 76 Test Detects 76 Novel Vaccine 76 Antibody Drug Conjugate 76 Novel Oral 76 FDA Approvals 76 Protein Linked 76 Lung Cancer Drug 75 Detect Cancer 75 Investigational Treatment 75 Rheumatoid Arthritis Drug 75 Could Revolutionize 75 Treatment Reduces 75 Submits Application 75 BioSante Pharmaceuticals Announces 75 Lowers Risk 75 Therapeutic Antibody 75 Cholesterol Lowering Drug 75 Phase 2b Clinical Trial 75 Treatment Shows Promise 75 Transdermal Patch 75 Submits Biologics License Application 75 Slow Progression 75 RNAi Therapeutic 75 Successfully Completes Phase 75 Announce Merger Agreement 75 Study Demonstrates 75 Prove Effective 75 Blood Thinner 75 Proves Effective 75 Phase 2a Trial 75 Significantly Improves 75 Helps Predict 75 Announces Initiation 75 Initiate Clinical Trial 75 Cholesterol Drug 75 Improves Outcomes 75 Anticancer Drug 75 Shown Effective 75 Successfully Treated 74 Vaccine Shows Promise 74 Blood Pressure Drug 74 Earns Milestone Payment 74 Oral Calcitonin 74 Gene Linked 74 Clinical Trial Results 74 Drug Combo 74 Anti Tumor 74 Researchers Identify 74 Tumor Targeting 74 Help Detect 74 Immunomedics Announces 74 Vaccine Adjuvant 74 Advanced Melanoma 74 FDA Approves Drug 74 Gene Variant 74 Proven Effective 74 AnaSpec Introduces 74 Being Studied 74 JAK2 Inhibitor 74 Collaborators Present 74 Prostate Cancer Vaccine 74 Initiate Phase III 74 Drug Resistant 74 Monoclonal Antibody 74 Scientists Identify 74 Contrast Agent 74 siRNA Delivery 74 Cancer Cells 74 Gets FDA Clearance 74 Demonstrates Positive 74 Demonstrates Significant 74 Exclusive License 74 Reports Preclinical Data 74 Could Detect 74 Less Invasive 74 Obtains Exclusive License 74 Recombinant Protein 74 Systemic Delivery 74 Mouse Model 74 Drug Prevents 74 Reduces Pain 74 Awarded Qualifying Therapeutic 74 Files Patent 74 Avian Flu Vaccine 74 IND Application 74 Announce Licensing Agreement 74 Topical Treatment 74 Cholesterol Lowering 74 Novel Antibiotic 74 Demonstrates Potential 74 Begins Shipment 73 Lupus Drug 73 Synthetic Peptide 73 Submits Supplemental 73 Phase 2b Trial 73 Awarded Patent 73 Brain Cells 73 Gout Drug 73 Patent Covering 73 Migraine Drug 73 Psoriasis Drug 73 Begins Dosing 73 Schizophrenia Drug 73 Ebola Vaccine 73 Immune Cell 73 Inhibits 73 Submits IND 73 Shows Efficacy 73 Can Detect 73 Protein Biomarker 73 Helps Identify 73 Cancer Treatments 73 Novel Treatments 73 FDA Accepts 73 Virus Linked 73 Granted Orphan Drug 73 Blood Clotting 73 Receive Milestone Payment 73 Malaria Vaccine 73 Generic Versions 73 Self Assembling 73 Companion Diagnostic 73 Disease Modifying 73 Treat Heart Failure 73 Vaccine Protects Against 73 Initiates Clinical Trials 73 Vaccine Candidate 73 AVI BioPharma Announces 73 Slows Progression 73 Therapeutic Vaccines 73 Smallpox Vaccine 73 Commercializes 73 Identifies Potential 73 Confirms Efficacy 73 Helps Prevent 73 Expanded Indication 73 Introduces Novel 73 Study Sheds Light 73 Tumor Growth 73 Skin Cells 73 Develops Innovative 73 Gene Mutation 73 Mylan Receives Approval 73 Biotech Firm 73 Single Dose 73 Investigational Compound 73 Provides Clues 73 Preclinical Study 73 Licenses Patents 73 Significantly Increases 73 Imaging Technique 72 Therapy Improves 72 Demonstrates Ability 72 Antiviral Drugs 72 Patient Enrollment 72 Widely Used 72 Mouse Models 72 Patients Treated With 72 Mimetics 72 Potentially Fatal 72 Kinase Inhibitor 72 Blood Vessels 72 Patent Issued 72 Circulating Tumor Cells 72 Device Helps 72 Anti Tumor Activity 72 Impotence Drug 72 Teva Provides Update 72 Study Evaluating 72 Phase III Clinical Trial 72 Completes Dosing 72 platform HDL Mimetic 72 Novel Antibody 72 Patients Suffering 72 Anticancer Activity 72 Improve Survival 72 Immunotherapeutic 72 Potentially Deadly 72 Jointly Develop 72 Help Predict 72 FDA Approves 72 Submits Response 72 Anti Angiogenesis 72 microRNA Therapeutics 72 Unlock Secrets 72 Anthrax Toxin 72 Inhaled Corticosteroids 72 Biomarker Study 72 Cocaine Addiction 72 Combo Therapy 72 Demonstrates Efficacy 72 Genotyping Test 72 PRN FDA Approves 72 Announce Licensing 72 Pooled Analysis 72 Anticancer Agent 72 Researchers Develop 72 Significantly Improved 72 Researchers Uncover 72 Antitumor Activity 72 Enrolls First 72 Receives CE Marking 72 Generic Version 72 Therapeutic Competitors Companies 72 Terminate Merger Agreement 72 Novel Protein 72 Genes Involved 72 Phase IIb Trial 72 Therapeutic Efficacy 72 Genetic Mutation 72 Announces License Agreement 72 Magnetic Nanoparticles 72 Osteoporosis Treatment 72 CysDisplay R 72 DNA Methylation 72 Clinical Trial Evaluating 72 Genes Identified 72 HER2 Positive 72 ORLive Presents 72 Awarded Patents 72 FDA Panel Recommends 72 Obtains License 72 First Patient Treated 72 Non Invasive Treatment 71 Extends Collaboration 71 Stem Cell Treatment 71 Successfully Tested 71 Adjuvant Treatment 71 Tyrosine Kinase Inhibitor 71 Anti Nausea 71 Launches Generic Version 71 Breast Cancer Recurrence 71 Receives Complete Response 71 Artificial Pancreas 71 Prostate Tumors 71 Inflammatory Disease 71 Taro Receives 71 Receives SFDA Approval 71 Obesity Linked 71 Osteoporosis Drugs 71 Drug Maker 71 Protects Against 71 Anti Inflammatory 71 Secures Financing 71 Licensing Pact 71 Newly Identified 71 Issued Patent 71 Postdoctoral Position 71 Helps Diagnose 71 Stomach Cancer 71 Aptamer 71 Successfully Treats 71 Breast Cancer Cells 71 Prostate Cancer Patients 71 Study Indicates 71 Scientists Uncover 71 Asthma Treatment 71 Gold Nanorods 71 Rotavirus Vaccine 71 FDA Warns 71 FDA Warns Against 71 Antifungal 71 Reduced Risk 71 Ultrasensitive 71 Combination Treatment 71 Prolongs Life 71 Genes Predict 71 Study Proves 71 Novel Method 71 Proves Successful 71 Seasonal Influenza Vaccine 71 Fungal Infections 71 Advanced Colorectal Cancer 71 Patients Receiving 71 Helps Detect 71 Bone Metastases 71 Protein Expression 71 Genetic Variant 71 Extend Collaboration 71 Nanoemulsion 71 Phase III Trial 71 TB Vaccine 71 Reveals Positive 71 Anti Inflammatory Drug 71 Metabolic Disease 71 Nano Scale 71 Lung Cancer Survival 71 Develops Novel 71 Receives Tentative Approval 71 Strongly Linked 71 Dramatically Increases 71 Therapeutic Potential 71 Study Evaluates 71 Enters Into Exclusive 71 Previously Treated 71 Detect Breast Cancer 71 Obtains Exclusive Rights 71 Gene Mutations 71 Investigational Agent 71 Study Validates 71 Initiates Phase 2b 71 Achieves Significant 71 STERIS Corporation Announces 71 Cholesterol Drugs 71 Increases Risk 71 Genes Associated 71 Endothelial Cells 71 REMINDER ORLive Presents 71 Guidelines Issued 71 Protein Involved 71 Announces Licensing Agreement 71 Vaccine Prevents 71 Tuberculosis Vaccine 71 Flamel Technologies Announces 71 Inflammatory Markers 71 Shingles Vaccine 71 Insulin Pen 71 Clinical Outcome 71 Antibiotic Resistant 71 Novel Mechanism 71 Milestone Payment From 71 Commences Phase 71 Significantly Reduces 71 SIX RO ROG 71 Study Casts Doubt 70 Abstract Accepted 70 Diagnostic Tests 70 Lanthanum Carbonate 70 Pivotal Study 70 Announces Tentative Approval 70 Nanophase Announces 70 Gene Variation 70 Metabolic Disorder 70 Introduces Revolutionary 70 Virus Infection 70 Presents Preclinical 70 Eases Pain 70 Vaccine Adjuvants 70 Gene Variants 70 Breast Tumors 70 Significantly Enhances 70 Beneficial Effects 70 Recurrent Breast Cancer 70 Reduces Mortality 70 Cervical Cancer Vaccine 70 Protein Synthesis 70 Male Contraceptive 70 Epilepsy Drugs 70 Generic Version Of 70 Improves Quality 70 Acquires Exclusive 70 Study Confirms 70 Boehringer Ingelheim MedImmune 70 Induces 70 Gives Clues 70 Recombinant Human 70 Begin Clinical Trials 70 Signs Licensing Agreement 70 Could Predict 70 Breast Cancer Metastasis 70 Pathogen Detection 70 Maven Semantic 70 Files Investigational 70 Metastatic Melanoma 70 Tumor Cells 70 Boosts Productivity 70 Expert Discusses 70 Regenerative Cells 70 Combination REOLYSIN R 70 Malaria Parasite 70 Genetic Predisposition 70 Successfully Completed 70 Nasal Powder 70 Therapeutic Vaccine 70 Liver Toxicity 70 Device Maker 70 Gene Silencing 70 Study Shows Benefits 70 Glaucoma Treatment 70 Nerve Regeneration 70 Anemia Drug 70 Artificial Skin 70 Severe Sepsis 70 Anti Angiogenic 70 Withdraws Application 70 Gastric Cancer 70 Crit Rev 70 Experimental Vaccine 70 Introduces Breakthrough 70 Predict Risk 70 Heartburn Drugs 70 Appears Safe 70 Impairs 70 Trial Evaluating 70 Demonstrates Sustained 70 Sangamo BioSciences Announces 70 Antidepressants Linked 70 Influenza Vaccine Production 70 Antisense Drug 70 Mutually Agree 70 Brain Metastases 70 Muscle Wasting 70 Microfluidic Devices 70 SBIR Grant 70 Cell Transplants 70 Brain Tumors 70 Avian Influenza Vaccine 70 Bone Marrow Cells 70 Leukemia Cells 70 Premenopausal Women 70 Brain Scans 70 Settle Patent Litigation 70 Minimally Invasive Procedure 70 First Patient Enrolled 70 Migraine Treatment 70 Deliver Powerful 70 Diabetic Foot Ulcer 70 Pharma Merck Serono 70 NDA Submission 70 Jointly Announce 70 Humanized Anti 70 Cancer Stem Cells 70 pralatrexate injection folate analogue 70 Idenix Novartis 70 Pharmaceuticals Initiates 70 Further Validates 70 Flagship Product 70 Treating Chronic 70 Phase IIb Clinical Trial 70 Genetic Tests 70 Inhaled Insulin 70 Immune Responses 70 Study Suggests 70 Amends Agreement 70 Investigational Oral 70 Antigen Specific 70 Investigational Drug 69 Help Smokers Quit 69 Phase 1b Clinical Trial 69 Unveils Groundbreaking 69 Diet Linked 69 Nerve Cell 69 Complicated Skin 69 Announces Discontinuation 69 Attenuates 69 Significantly Improve 69 Receives Fast Track 69 Well Tolerated 69 Improve Diagnosis 69 Pre Cancerous 69 Bush Embraces Pause 69 Data Suggest 69 Delivers Next Generation 69 Improved Survival 69 Enrolling Patients 69 Bird Flu Vaccine 69 Inks License 69 Receptor Agonist 69 Study Shows Promise 69 Genetic Disorder 69 Demonstrates Potent 69 Report Analyzes 69 Completes Tender Offer 69 Insulin Resistance 69 Myeloma Patients 69 Could Save Lives 69 Strengthens Position 69 Treatment Naïve 69 Patent Lawsuit 69 Complete Merger 69 Significantly Reduced 69 Clinical Study Shows 69 License Pact 69 Lowers Cholesterol 69 Using Dip Pen 69 IND Filing 69 Molecular Diagnostic 69 Announce Initiation 69 Reduce Risk 69 Demonstrates Statistically Significant 69 Phase III Trials 69 Improve Outcomes 69 Unveils Revolutionary 69 Study Compares 69 Non Invasive 69 Fat Cells 69 Hepatitis C Treatment 69 Low Dose 69 Study Explores 69 Study Identifies 69 Initiate Phase 69 Novel Inhibitor 69 Node Positive 69 Modulates 69 Findings Suggest 69 Subsidiary Enters 69 Orally Active 69 Carbon Nanotube Based 69 Achieves Primary Endpoint 69 Survival Benefit 69 Signs License Agreement 69 Anticancer Compound 69 Insights Into 69 Muscle Function 69 Diet Pill 69 Protease Inhibitor 69 Initiates Phase 69 HCV Protease Inhibitor 69 Increased Risk 69 Therapy Shows Promise 69 Breast Cancer Patients 69 FDA Approves Generic 69 Trial Halted 69 Scientists Unravel 69 Launches Unique 69 Smooth Muscle 69 Levels Linked 69 Licensing Deal 69 Study Showed 69 Nerve Cells 69 Renal Cell Carcinoma 69 Helps Smokers Quit 69 Adenoma 69 Scientist Discovers 69 Heart Stents 69 Enters Into Collaboration 69 HuCAL PLATINUM R 69 Viral Infections 69 Hsp# Inhibitor 69 Implantable Device 69 Discontinues 69 NICE Recommends 69 Aggressive Prostate Cancer 69 Receives Positive Opinion 69 Announces Publication 69 Artery Disease 69 Deliver Innovative 69 Shows Statistically Significant 69 Fast Track Status 69 Prevent Breast Cancer 69 Therapeutic Competitors Report 69 Randomized Trials 69 Inflammatory Arthritis 69 Novel Peptide 69 Gum Disease 69 Enlarged Prostate 69 Transdermal Delivery 69 TNF Blockers 69 Novel Compound 69 Dry Powder Inhaler 69 Lung Cancer Patients 69 Live Attenuated 69 Settle Patent Dispute 69 Extend Partnership 69 Can Predict 69 Mg Usa 69 Cases Linked 69 Treated Patients 69 Significantly Expand 69 Technological Advances 69 Breast Tumor 69 Reports Positive 69 Anemia Drugs 69 Previously Untreated 69 Vitrasert R 69 Treating Depression 69 Patients Undergoing 69 Ovarian Cancer Patients 69 Breast Cancer Stem Cells 69 Contrast Agents 69 Announce Agreement 69 Commence Phase 69 Useful Tool 69 Provide Comprehensive 69 Spins Off 69 Statistically Significant 69 Statin Drugs 69 Colon Polyps 69 Phase 2b Study 69 Secures Additional 69 Expands Portfolio 69 Effective Than 69 Genes Discovered 69 Prevent Spread 69 Beta Blocker 69 Kinase Inhibitors 69 Skeletal Muscle 69 Settle Patent 69 Inflammatory Diseases 69 Prophylactic Treatment 69 Introduces Next Generation 69 Gene Expression Analysis 69 Deadly Bacteria 69 Carbon Nanotube 69 Receives Funding 69 Autoimmune Disease 69 Cognitive Deficits 69 Advanced Prostate Cancer 69 Merge Healthcare Announces 68 BiTE Antibody 68 Multiple Myeloma Patients 68 Clinical Trial Enrollment 68 Milestone Payments 68 Conjugate 68 Terminates Contract 68 Oral Fingolimod 68 Help Diagnose 68 Disease Causing 68 Aurora Kinase 68 Hematology Molecular Pathology 68 Is Well Tolerated 68 Could Prevent 68 Enter Into 68 Signs Merger Agreement 68 Coronary Arteries 68 Atopic Dermatitis 68 Help Prevent 68 Wins Patent Infringement 68 Phase 2a Clinical Trial 68 Announces Presentation 68 Testosterone Patch 68 Whole Genome Sequencing 68 Pandemic Flu Vaccine 68 See CLINICAL PHARMACOLOGY 68 Provides Update Regarding 68 Secures Funding 68 Ultra Sensitive 68 Vascular Inflammation 68 Weight Loss Drug 68 Postmenopausal Osteoporosis 68 Hepatocellular 68 Fewer Side Effects 68 Deliver Comprehensive 68 Lowers Blood Pressure 68 Therapy Reduces 68 Cell Proliferation 68 Sign Definitive Agreement 68 Broadens Its 68 Extracellular Matrix 68 Diabetic Neuropathy 68 Spins Out 68 Yields Clues 68 Gene Therapy Trial 68 Stem Cell Procedure 68 Healthbeat Report 68 JAK Inhibitor 68 Receives Favorable 68 Gene Mutation Linked 68 Biogen Genentech 68 Demonstrated Significant 68 Increased Mortality 68 Presents Positive Preclinical 68 Pandemic Influenza Vaccine 68 Phase IIa Clinical Trial 68 Patent Infringement Litigation 68 Deliver Integrated 68 Patents Covering 68 Contrast Enhanced 68 Hypertensive Patients 68 Teledyne Acquires 68 Meta Analysis 68 VIVUS Announces 68 Advisers Urge 68 Often Misdiagnosed 68 Breast Cancer Treatment 68 Suppresses 68 Embryonic Stem Cells 68 Bioartificial Liver 68 Be Cured 68 Allergic Reactions 68 Namenda Memantine HCl 68 Aeolus Pharmaceuticals Announces 68 Resistant Hypertension 68 Wins Approval 68 Genetic Markers 68 Jointly Offer 68 Acne Scars 68 Treat Anemia 68 Viral Infection 68 Blood Clots 68 Autoimmune Diseases 68 Atypical Antipsychotic 68 Announce Definitive Agreement 68 Buy Privately Held 68 Study Pinpoints 68 Therapeutic Targets 68 Tissue Engineered 68 Unveils Innovative 68 Files Provisional 68 Successfully Completes Tender Offer 68 Immunomodulatory 68 Antipsychotic Drug 68 Substantially Reduce 68 Therapeutic Antibodies 68 Achieves Breakthrough 68 Announce Expanded 68 Provides Detailed 68 Predict Dementia 68 Desvenlafaxine Succinate 68 Molecular Mechanism 68 Contaminant Found 68 Arterial Disease 68 Oral Formulation 68 Hold Clues 68 First Patient Dosed 68 Minimally Invasive Treatment 68 Adjunctive Therapy 68 Improves Accuracy 68 FDA Cracks Down 68 Launches Next Generation 68 Rheumatoid Arthritis Patients 68 Potential Dangers 68 Long Term Efficacy 68 Showed Significant 68 Refractory Hodgkin Lymphoma 68 Agonist MABA program 68 Neoadjuvant Chemotherapy 68 Chemotherapeutic Agents 68 Anti CD# Antibody 68 Exercises Option 68 Fortifies 68 Brain Atrophy 68 Announce Breakthrough 68 Doctors Warn 68 Hormone Receptor Positive 68 Tezampanel 68 Inhaled Nitric Oxide 68 Dose Escalation 68 Human Monoclonal Antibodies 68 Correlation Between 68 BioElectronics Announces 68 Announces Immediate Availability 68 Adjuvant Chemotherapy 68 Ligands 68 Confirms Commitment 68 Susceptibility Testing 68 FDA Clearance 68 Image Guided 68 Transdermal Drug 68 Sniffing Out 68 Biomolecules 68 Announce Exclusive 68 candidates Azedra 68 Asthma COPD 68 Testosterone Gel 68 Antitumor 68 Predict Breast Cancer 68 Improve Patient 68 Provide Enhanced 68 AUDIO PROVIDED BY 68 Collaborates With 68 Deliver Enhanced 68 Inks Licensing Deal 68 Mg Uk 68 Unveils Expanded 68 Effective Treatments 68 Settles Litigation 68 Pneumonia Vaccine 68 Patent Lawsuit Against 68 Study Analyzes 68 Announces Issuance 68 Successfully Tests 68 Acquire Controlling Interest 68 Prostate Cancer Treatment 68 Peripheral Arterial 68 Kidney Function 68 Clinical Proteomics 68 Announce Launch 68 Key Milestones 68 Expand Relationship 68 Improve Patient Safety 68 Replacement Therapy 68 Genetic Makeup 67 Low Doses 67 Assay Kits 67 Signaling Pathway 67 Kidney Transplant Patients 67 Announce Settlement 67 COMUNICADO 67 Innovative Approach 67 Treatment Experienced 67 Chemotherapeutic 67 Skin Infections 67 Doripenem 67 Mitral Valve Repair 67 Receives Positive 67 Smoking Linked 67 Crucell Announce 67 Nano Particles 67 Help Manage 67 Oral Mucositis 67 Significant Improvements 67 Study Examines 67 Stronger Warnings 67 Blood Stem Cells 67 Mesothelioma Treatment 67 Platform Enables 67 Controlled Study 67 Files Patent Infringement 67 Urine Test 67 Poorly Controlled 67 Retinal Diseases 67 Internationally Recognized 67 Acquire Assets 67 Epithelial 67 Novel Therapies 67 Regenerative Cell 67 Introduces Innovative 67 Pediatric Patients 67 IG HCR ;) CO 67 Pulmonary Arterial Hypertension 67 Blood Vessel 67 Amend Merger Agreement 67 Metastatic Cancer 67 Epidermal Growth Factor Receptor 67 Nanofiber 67 Neuromuscular Disorders 67 Silicone Breast Implants 67 Progenitor Cell 67 Relieves Pain 67 Sustained Release 67 Exploit collaboration 67 Tumor Targeted 67 Takeda Kyowa Hakko Kirin 67 Regrow 67 Bioresorbable 67 Brain Tumor Patients 67 Announce Availability 67 Altera Ships 67 Heart Failure Patients 67 Dose Finding 67 Supplemental Biologics License Application 67 Pharmacyclics Announces 67 Enhances User Experience 67 Exposure Linked 67 Chronic Inflammation 67 Accelrys Announces 67 Inc Therapeutic Competitors 67 Mental Decline 67 Expands Capabilities 67 Hepatitis B Vaccine 67 Novartis Organon 67 Provides Comprehensive 67 Commonly Prescribed 67 Restructures Debt 67 Transplant Patient 67 Rotavirus Vaccines 67 Lung Cancers 67 Sinus Infections 67 Drug Coated Stent 67 Study Links 67 Patients Enrolled 67 Sniffs Out 67 var arrMeta = 67 Receives Clearance 67 Treatment Regimen 67 Helicos BioSciences Announces 67 Biologic Therapy 67 Genetic Clues 67 Neural Stem Cell 67 Recall Issued 67 Embolic Protection 67 Expand Scope 67 Helps Reduce 67 Significantly Reduce 67 Chronic Hepatitis B 67 Develops Breakthrough 67 Cervical Dysplasia 67 Autoimmune Disorders 67 Artificial Cornea 67 Patent Infringement Suit 67 PDL BioPharma Announces 67 Bacterial Infection 67 Neural Stem Cells 67 Crofelemer budesonide foam 67 Imaging Techniques 67 lead molecular radiotherapeutic 67 Nasal Sprays 67 Sleep Disturbances 67 Validates 67 Restructures Operations 67 Hepatic Encephalopathy 67 #nm Process 67 Antiangiogenic 67 Eliminates Need 67 Transplant Patients 67 Accelerate Adoption 67 Delivers Breakthrough 67 Cholesterol Lowering Drugs 67 Randomized Clinical Trials 67 Biocompatibility 67 HER2 Positive Breast Cancer 67 Receives Certification 67 Seeks Approval 67 Ovarian Cancers 67 Lupus Nephritis 67 Nano Sized 67 Finalize Agreement 67 Successfully Complete 67 Method Developed 67 Efficacy Trial 67 Voluntarily Withdraws 67 Carboplatin Paclitaxel 67 Predict Prostate Cancer 67 Blood Thinning 67 Randomized Double Blind 67 Oral Suspension USP 67 Liver Tumors 67 Molecular Basis 67 Clinical Evaluation 67 Multi Billion Dollar 67 Obtains Patent 67 Single Molecule 67 FDA Approves Novel 67 NMDA Receptor 67 Rapidly Growing 67 Strengthens Its 67 Soft Tissue Sarcoma 67 INDUSTRY ASSESSMENTS 67 Files Patents 67 Celebrates Decade 67 Toshiba Develops 67 Relapsed Refractory 67 Bone Fractures 67 Cancer Vaccine 67 Announces Successful Completion 67 Schizophrenia Treatment 67 Accurately Predicts 67 Lower Blood Pressure 67 Explore Strategic Alternatives 67 Adenoviral 67 Osteoarthritis Patients 67 Patent Infringement Case 67 Patent Infringement Lawsuit 67 Important Milestone 67 Relieve Pain